PLK4 and breast cancer: For example, PLK4-driven centrosome amplified breast tumor cells have been reported to be highly sensitive to inhibitors of the STAT3 (signal transducer and activator of transcription 3) protein [135], an emerging potential therapeutic target in breast cancer [136].